CN113456535A - Nail polish gel meeting European Union personal use standard - Google Patents
Nail polish gel meeting European Union personal use standard Download PDFInfo
- Publication number
- CN113456535A CN113456535A CN202110977353.7A CN202110977353A CN113456535A CN 113456535 A CN113456535 A CN 113456535A CN 202110977353 A CN202110977353 A CN 202110977353A CN 113456535 A CN113456535 A CN 113456535A
- Authority
- CN
- China
- Prior art keywords
- parts
- photoinitiator
- nail polish
- diol
- polish gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003085 diluting agent Substances 0.000 claims abstract description 38
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims abstract description 26
- 102100026735 Coagulation factor VIII Human genes 0.000 claims abstract description 23
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims abstract description 23
- 238000004821 distillation Methods 0.000 claims abstract description 22
- 230000002829 reductive effect Effects 0.000 claims abstract description 19
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical group OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- -1 polybutylene adipate Polymers 0.000 claims description 45
- 238000006116 polymerization reaction Methods 0.000 claims description 30
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 claims description 29
- 239000003112 inhibitor Substances 0.000 claims description 28
- 150000002009 diols Chemical class 0.000 claims description 27
- 239000003292 glue Substances 0.000 claims description 27
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 19
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 17
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012948 isocyanate Substances 0.000 claims description 10
- 150000002513 isocyanates Chemical class 0.000 claims description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical group CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 8
- 229920001610 polycaprolactone Polymers 0.000 claims description 8
- 239000004632 polycaprolactone Substances 0.000 claims description 8
- 239000004417 polycarbonate Substances 0.000 claims description 8
- 229920000515 polycarbonate Polymers 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 229920000909 polytetrahydrofuran Polymers 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002981 blocking agent Substances 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 6
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical group CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 5
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 4
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical group CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 claims description 3
- 239000012975 dibutyltin dilaurate Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 3
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 claims description 2
- 229920001748 polybutylene Polymers 0.000 claims description 2
- HLBDSCLVARHEHJ-UHFFFAOYSA-N cyclohexane;hexane-1,6-diol;methanol Chemical compound OC.OC.C1CCCCC1.OCCCCCCO HLBDSCLVARHEHJ-UHFFFAOYSA-N 0.000 claims 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 abstract description 24
- 239000000126 substance Substances 0.000 abstract description 11
- 206010040880 Skin irritation Diseases 0.000 abstract description 10
- 230000036556 skin irritation Effects 0.000 abstract description 10
- 231100000475 skin irritation Toxicity 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000014759 maintenance of location Effects 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 5
- 230000000172 allergic effect Effects 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 4
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 15
- 229920001577 copolymer Polymers 0.000 description 15
- 239000000178 monomer Substances 0.000 description 10
- 238000009835 boiling Methods 0.000 description 9
- 238000001723 curing Methods 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 206010074268 Reproductive toxicity Diseases 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 231100000372 reproductive toxicity Toxicity 0.000 description 7
- 230000007696 reproductive toxicity Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 4
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 230000001850 reproductive effect Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- 238000004383 yellowing Methods 0.000 description 3
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000003848 UV Light-Curing Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940106012 diethylene glycol adipate Drugs 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 2
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 231100000687 reproductive toxin Toxicity 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000010023 transfer printing Methods 0.000 description 2
- PMDHMYFSRFZGIO-UHFFFAOYSA-N 1,4,7-trioxacyclotridecane-8,13-dione Chemical compound O=C1CCCCC(=O)OCCOCCO1 PMDHMYFSRFZGIO-UHFFFAOYSA-N 0.000 description 1
- BUOPYOGQBUMALK-UHFFFAOYSA-N 1,5-dioxacycloundecane-6,11-dione Chemical compound O=C1CCCCC(=O)OCCCO1 BUOPYOGQBUMALK-UHFFFAOYSA-N 0.000 description 1
- FECNOIODIVNEKI-UHFFFAOYSA-N 2-[(2-aminobenzoyl)amino]benzoic acid Chemical class NC1=CC=CC=C1C(=O)NC1=CC=CC=C1C(O)=O FECNOIODIVNEKI-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- DUDLPNYTDGRKNN-UHFFFAOYSA-N 2-morpholin-4-yl-1-phenylbutan-1-one Chemical compound C=1C=CC=CC=1C(=O)C(CC)N1CCOCC1 DUDLPNYTDGRKNN-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- SXFJDZNJHVPHPH-UHFFFAOYSA-N 3-methylpentane-1,5-diol Chemical compound OCCC(C)CCO SXFJDZNJHVPHPH-UHFFFAOYSA-N 0.000 description 1
- ILKNNHYSEPMBSD-UHFFFAOYSA-N 4-methoxyphenol Chemical compound COC1=CC=C(O)C=C1.COC1=CC=C(O)C=C1 ILKNNHYSEPMBSD-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- ZQNAKXJCPVQGDX-UHFFFAOYSA-N C1CCOC1.CC(C)(CO)CO Chemical compound C1CCOC1.CC(C)(CO)CO ZQNAKXJCPVQGDX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- ORLQHILJRHBSAY-UHFFFAOYSA-N [1-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1(CO)CCCCC1 ORLQHILJRHBSAY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- KMHIOVLPRIUBGK-UHFFFAOYSA-N butane-1,4-diol;hexane-1,6-diol Chemical compound OCCCCO.OCCCCCCO KMHIOVLPRIUBGK-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- VJIXTWBTDVCSSV-UHFFFAOYSA-N hexane-1,6-diol;[4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCCCCCCO.OCC1CCC(CO)CC1 VJIXTWBTDVCSSV-UHFFFAOYSA-N 0.000 description 1
- XTBJSRPRFRBLIP-UHFFFAOYSA-N hexane-1,6-diol;pentane-1,5-diol Chemical compound OCCCCCO.OCCCCCCO XTBJSRPRFRBLIP-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a nail polish gel which meets the individual use standard of European Union, and the raw materials of the nail polish gel comprise oligomer, photoinitiator and reactive diluent which is treated by reduced pressure distillation; the oligomer is urethane acrylate; the photoinitiator consists of one or more of 184 photoinitiator, 1173 photoinitiator, 819 photoinitiator and TPO-L photoinitiator; the reactive diluent treated by reduced pressure distillation does not comprise HEMA. The nail polish gel meeting the individual use standard of European Union eliminates TPO and MEHQ which are harmful substances to human body, and an active diluent with low skin irritation, does not use HEMA which is an active diluent, and selects PUA with low skin irritation, thereby reducing allergic factors to human body and ensuring the individual use safety. The nail polish gel has the advantages of easy operation, low irritation, long retention time, wide application range, safety and the like.
Description
Technical Field
The invention relates to nail polish gel, in particular to nail polish gel meeting the individual use standard of European Union.
Background
At present, nail art is a beautifying art for hand decoration, and has a history of over 500 years to date, and the modern nail art goes through three stages.
(1) An oily nail polish stage; it can reach the effect of film-forming nail beautification by solvent volatilization. The following drawbacks exist: the volatilization of the solvent causes environmental pollution, and the low ignition point easily causes fire hazard; the film is not long in retention time after being formed, and the dry film state is easily damaged by cleaning fluid and the like in daily life; the product contains nitrocellulose, a plasticizer, resin and volatile organic solvent, and can damage the natural protective layer on the surface of the nail after long-term use, so that the nail becomes thin and brittle, if the nail is coated too thickly, the nail can be prevented from breathing, and the nail can become yellow, dark and lustrous.
(2) A water-based nail polish stage; the film forming effect is achieved by volatilization of water, and the nail polish is environment-friendly; has the following disadvantages: the water resistance is insufficient, namely the water-resistant paint is easy to fall off after meeting water; the adhesive force is poor, and the difference is great compared with the ester solvent type nail polish; the problem that the detergent can fall off after being washed by warm water, soapy water and washing powder exists; after drying, the surface of the paint can be sticky again when meeting oil dirt; drying is too slow, and surface drying generally takes anywhere from a few minutes to tens of minutes, and even longer when it is dry.
(3) UV methyl lacquer glue stage; it is composed of light-cured resin, active diluent, photoinitiator, pigment, filler and the like; promoting a photoinitiator to generate free radicals by ultraviolet light, and then initiating the polymerization crosslinking of the resin and the reactive diluent; is the most popular nail art at present.
At present, the UV nail polish glue has the following advantages: the method is efficient: under the irradiation of an ultraviolet lamp, the curing can be completed within two minutes; environment-friendly: the oligomer and the reactive diluent both participate in the process of curing and film forming, and no solvent is volatilized; performance: the transparency is high after the film is solidified and formed; the toughness is good; fourthly, the coating film with excellent weather resistance and no yellowing can be prepared; the cross-linking density of the coating is high, the corrosion resistance is strong, and the retention time is long; sixthly, the UV nail polish gel with different performance requirements can be developed according to the difference of the application, such as: the glue is a diamond sticking glue, a carving glue, a line hooking glue, a metal glue, a gem glue, a transfer printing glue, a cat-eye glue, a transparent nail polish glue, a temperature-variable carving glue, a transfer printing glue, a temperature-variable glue, a water color glue, an optically variable glue, a one-step glue, a silk drawing glue, a bursting glue and the like.
The domestic nail polish gel is popularized and used in the market in the next half year of 2009, and compared with European Union, the regulations of the domestic nail polish gel on the aspect of use safety are yet to be further improved. The European Union has strict screening principles on nail polish gum components, and the composition standards and application ranges of the components of the UV nail polish gum used by professional lines and individuals of the European Union are as follows:
at present, most of domestic nail polish gel products are suitable for the category of professional lines of nail salons and nail shops; but does not meet personal use standards.
Therefore, there is a need to design a new nail polish gel which meets the use standards of individual European Union to overcome the above problems.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide nail polish gel which meets the individual use standard of European Union, eliminates substances TPO and MEHQ which are harmful to human bodies, and active diluent with low skin irritation, does not use active diluent HEMA, selects PUA with low skin irritation, reduces allergic factors to human bodies, and ensures the individual use safety. The nail polish gel has the advantages of easy operation, low irritation, long retention time, wide application range, safety and the like.
The invention is realized by the following steps:
the invention provides a nail polish gel which meets the individual use standard of European Union, and the raw materials of the nail polish gel comprise oligomer, photoinitiator and reactive diluent which is treated by reduced pressure distillation;
the oligomer is urethane acrylate;
the photoinitiator consists of one or more of 184 photoinitiator, 1173 photoinitiator, 819 photoinitiator and TPO-L photoinitiator;
the reactive diluent treated by reduced pressure distillation does not comprise HEMA.
Further, the polyurethane acrylate is composed of dihydric alcohol, isocyanate, a blocking agent, a catalyst and a polymerization inhibitor.
Further, the isocyanate is isophorone diisocyanate, dicyclohexylmethane-4, 4-diisocyanate or hexamethylene diisocyanate.
Further, the catalyst is dibutyltin dilaurate, tetrabutylammonium bromide, triethylamine or triphenylphosphine;
further, the end-capping agent is a methacrylate functionalized with hydroxyl groups.
Further, the diol is polytetrahydrofuran and copolyether diol thereof, polytetrahydrofuran diol, polybutylene adipate diol, diethylene glycol adipate diol, polyhexamethylene glycol adipate diol, polyethylene glycol propylene glycol adipate diol, polyethylene glycol adipate diol, polybutylene glycol adipate diol, polyhexamethylene glycol neopentyl glycol adipate diol, 1.6-hexanediol polycarbonate diol, cyclohexanedimethanol polycarbonate-1.6-hexanediol diol, 1.5-pentanediol polycarbonate-1.6-hexanediol diol, 1.4-butanediol-1.6-hexanediol polycarbonate diol, polycaprolactone diol, or polycaprolactone diol.
Further, the polymerization inhibitor is 2, 6-di-tert-butyl-p-cresol.
Further, the nail polish glue is used for preparing a primer, and the primer comprises the following components in parts by mass:
LT 201035-45 parts
LT 201827-37 parts
25-35 parts of HPMA
1-4 parts of 184 photoinitiator
TPO-L photoinitiator 1-4 parts
0.1-0.5 part of BYK-333 leveling agent.
Further, the nail polish gel is used for preparing a color gel, and the color gel comprises the following components in parts by mass:
LT 202138-48 parts
LT 201313-23 parts
20-30 parts of PEG400DA 20
5-15 parts of HPMA
1-4 parts of 184 photoinitiator
819 parts of photoinitiator 0.1-3
TPO-L photoinitiator 1-4 parts
0.2-0.5 part of BYK-333 leveling agent
0.1 to 2 portions of color paste
0.1-1.6 parts of R974 anti-settling agent.
Further, the nail polish glue is used for preparing a seal layer, and the seal layer comprises the following components in parts by mass:
LT 201037-47 parts
LT 201520-30 parts
13-23 parts of PEGDMA
10-20 parts of HPMA
3-5 parts of TPO-L photoinitiator
0.1-0.5 part of BYK-333 leveling agent.
The invention has the following beneficial effects:
the nail polish gel meeting the individual use standard of European Union eliminates TPO and MEHQ which are harmful substances to human body, and an active diluent with low skin irritation, does not use HEMA which is an active diluent, and selects PUA with low skin irritation, thereby reducing allergic factors to human body and ensuring the individual use safety. The nail polish gel has the advantages of easy operation, low irritation, long retention time, wide application range, safety and the like.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a nail polish gel which meets the individual use standard of European Union, and the raw materials of the nail polish gel comprise oligomer, photoinitiator and reactive diluent which is treated by reduced pressure distillation. The reactive diluent is a commercial reactive diluent for UV curing reaction, but does not contain HEMA, and the content of the IBOMA and the content of the MEHQ can be reduced after the vacuum distillation treatment of the commercial reactive diluent.
The oligomer is a urethane acrylate. The photoinitiator consists of one or more of 184 photoinitiator, 1173 photoinitiator, 819 photoinitiator, and TPO-L photoinitiator. The reactive diluent treated by reduced pressure distillation does not include HEMA (hydroxyethyl methacrylate).
Selection of the photoinitiator:
according to the classification of ECHA (European Chemicals Agency, ECHA for short) as a photoinitiator for LED and UV photocuring, TPO may be re-classified as a reproductive toxicity class 1B substance in CMR substance (hereinafter called as carcinogenic, mutagenic or reproductive toxicity class). TPO is now classified as reproductive toxicity 2 and has been classified based on actual data. With the addition of more experimental data, it is likely that TPO would be classified as reproductive toxicity class 1B.
The classification of CMR agents is based on the three separate classifications of carcinogenic, mutagenic and reproductive toxicity. In the CLP Regulation of the European Union (English name: Classification, laboratory and Packaging Regulation, Chinese name: Classification, labeling and Packaging Regulation), there are two categories of reproductive toxic substances, 1 and 2, respectively, and 1 is further classified into 1A and 1B. 1A refers to "Known reproductive toxicity (knock human reproductive toxin)" in humans, and is based on evidence from a large number of humans. And 1B means "Presumed to be reproductive toxic (pre-human reproductive toxin) to humans", and is evidence based on a number of animal experiments. For class 2, i.e., suspected of being reproductive toxic, based on evidence obtained from a human or laboratory animal, there may be additional evidence of adverse effects on sexual function and fertility, or development, but the evidence is not sufficient to convincingly list the substance as class 1, the substance is listed as reproductive toxic class 2.
Photoinitiators which have now been listed by the European Union ECHA as CMR reproductive toxicity 1B include morpholinobutyrophenone (CAS: 119313-12-1) (alias 369), 2-ethylhexyl 4- (dimethylamino) benzoate (CAS: 21245-02-3) (EHA for short), ethyl 4- (dimethylamino) benzoate (CAS: 10287-53-3) (EDB for short), 4-phenylbenzophenone (CAS: 2128-93-0) (PBZ for short) and 2-methyl-2- (4-morpholinyl) -1- [4- (methylthio) phenyl ] -1-propanone (CAS: 71868-10-5) (alias 907 for short). The use of all the photoinitiators listed in CMR 1B is very limited and can be banned in many products, in particular food-related products and products in close contact with the human body. From the data provided by ECHA, 819 and TPO-L present no reproductive health risk problems. Concerns for skin sensitivity are raised for 819, while there are no considerations that need to be addressed for TPO-L, neither risk being disabled.
Thus the photoinitiator of the present invention was selected from 184 photoinitiator, 1173 photoinitiator, 819 photoinitiator and TPO-L photoinitiator.
Selection of a polymerization inhibitor:
the MEHQ polymerization inhibitor is added to most of active diluents and oligomers on the market, and has the following characteristics: MEHQ (p-hydroxyanisole (4-Methoxyphenol)) application: the product is mainly used for polymerization inhibitors, ultraviolet inhibitors and dye intermediates of styrene, acrylic esters, acrylonitrile, vinyl acetate and other olefin monomers, and is used for synthesizing edible oil and fat, cosmetics and antioxidants BHA and the like. MEHQ is an effective polymerization inhibitor at low temperatures, but decomposes at high temperatures to lose its polymerization inhibiting effect, so that it is a good polymerization inhibitor for monomer storage and does not need to be removed before polymerization. Risk: is toxic; the toxic effects and even death after a single (or multiple 24-hour) dose of MEHQ are reported as: oral-rat LD 50: 1600 mg/kg; peritoneal cavity-mouse LD 50: 250 mg/kg; skin-rabbit 6000 mg/12 days mild intoxication; the flammability hazard property is flammable; the fire ground releases acrid and hot to stimulate smoke.
Because MEHQ has the potential safety hazard, a polymerization inhibitor which has good safety, low addition amount, light color and no yellowing or low yellowing in free radical polymerization needs to be found in the patent.
The polymerization inhibitor screening operation is as follows:
firstly, carrying out safety evaluation and hue screening on known polymerization inhibitors on the market, finding out polymerization inhibitors with light colors and good free radical polymerization inhibition effect, and respectively numbering the polymerization inhibitors A, B, C and D.
Secondly, sequentially adding the screened polymerization inhibitors A, B, C and D.once to the same reactive diluent and oligomer respectively, wherein the polymerization inhibitors have the same concentration, baking the mixture in a 70 ℃ oven after preparation, testing the viscosity change of the mixture in 6 days, 10 days and 15 days respectively, and finding out 1 group of polymerization inhibitor A1 with the minimum comprehensive viscosity change and hue change
Thirdly, 6-10 groups of polymerization inhibitor A1 screened out to have the best test result are respectively configured according to the principle of proportional increasing, further oven test is carried out, the temperature is constant at 75 ℃, the polymerization inhibitor A1 is taken out after 15 days, the viscosity value of the polymerization inhibitor A1 is tested, and a group of experimental data with low viscosity value change and the minimum addition amount of the polymerization inhibitor is found out, so that the type and the optimum addition amount of the polymerization inhibitor needed by the company are determined, and the polymerization inhibitor A1 is added into the active diluent and the oligomer.
According to the mode, the invention finds a BHT polymerization inhibitor which is named as 2, 6-di-tert-butyl-p-cresol.
Selection of reactive diluents:
HEMA is one of the most widely used hydroxyl functional methacrylic acid active monomers in the nail polish glue industry, and has the characteristics of high curing speed, small smell, good glossiness, moderate hardness, low price and the like. SCCS (european union consumer safety science committee) however, indicates that HEMA is a weak to moderate allergenic substance that poses sensitization risks in cases of abuse, misuse or contact with the skin around the nail cover when used under normal and reasonably foreseeable conditions. In the evaluation of "use under normal and reasonably predictable conditions", abuse, misuse or misuse situations that may occur must also be taken into account in the evaluation. Meanwhile, if the product needs to be matched with accurate conditions for use, the condition of not being accurate enough needs to be considered. SCCS considers that the use of a nail product containing a HEMA component by ordinary consumers should take into account the possibility of contacting the skin around the nail cover, with the risk of human health. The professional has more skill, experience and knowledge in cosmetic use than the ordinary consumer, and is safer when using the nail product containing the HEMA component.
Based on the above considerations, HEMA is only used by professional persons when used for nail products, and needs to add a specific warning slogan 'which is only used by professional persons and causes allergic reaction'. 2-hydroxyethyl methacrylate (HEMA, CAS number 868-77-9) was also approved by the European Committee on revision EU 2020/1682 on 12.11.2020, as a cosmetic limiting substance, and is only used by professional nail products. HEMA is regulated by european union cosmetic code appendix III, clause 313. Products not compliant with the new provisions will be banned from the market in the european union from 6/3/2021 and from the market in the european union from 9/3/2021.
Therefore, HEMA was not considered when choosing a reactive diluent.
Solution of MEHQ content reduction in reactive diluent (low MEHQ reactive diluent preparation):
the content of UV methyl lacquer MEHQ is less than 10ppm according to personal use standards. In most of the products in the market, the content of MEHQ in the active diluent and the oligomer is about 200ppm, so the content of MEHQ in the active diluent can be reduced by the following reduced pressure distillation method
1. In view of the fact that the MEHQ content of commercially available reactive diluents for UV curing reaction is about 200ppm, the object of this experiment was to reduce the MEHQ content of IBOMA (isobornyl methacrylate) and HPMA (hydroxypropyl methacrylate) reactive diluents by distillation under reduced pressure, and to enable the incorporation of the diluent into all reactive diluents.
(1) The data describes the relationship between boiling point and atmospheric pressure for MEHQ, HPMA and IBOMA as follows:
the corresponding relationship between the boiling point of MEHQ and the atmospheric pressure is as follows:
boiling point | Atmospheric pressure | Mercury column | |
MEHQ | 223.8°C | 101.325kPa | 760 mmHg |
The relationship between the boiling point of HPMA and the atmospheric pressure is as follows:
boiling point | Atmospheric pressure | Mercury column | |
HPMA | 96℃ | 1.33kPa | 9.9758204mmHg |
HPMA | 209.4℃ | 101.325kPa | 760 mmHg |
HPMA | 57℃ | 66.7Pa | 0.50029114mmHg |
The correspondence between the IBOMA boiling point and the atmospheric pressure is as follows:
boiling point | Atmospheric pressure | Mercury column | |
IBOMA | 120℃ | 800pa | 6.0004935mmHg |
IBOMA | 263.1°C | 101.325kPa | 760 mmHg |
According to the data, the following data are estimated:
boiling point after decompression | Boiling point at atmospheric pressure | Mercury column | Reduced pressure | |
MEHQ | 50℃ | 223.8℃ | 0.7mmHg | 93.325pa |
HPMA | 42℃ | 209.4℃ | 0.7mmHg | 93.325pa |
IBOMA | 79℃ | 263.1℃ | 0.7mmHg | 93.325pa |
Accordingly, IBOMA and HPMA rectification products were obtained by vacuum distillation while controlling the pressure at 93.325 Pa.
1. The specific operation method of IBOMA rectification is as follows: adding IBOMA liquid to be distilled into a double-neck distillation flask to 1/2 of the volume of the flask, closing a piston on a safety bottle, adjusting the pressure in the distillation flask to 93.325pa by using an oil pump, starting heating by using an oil bath after the pressure is stabilized, controlling the temperature of a hot bath at 55 ℃, preferably controlling the distillation speed to be 0.5-1 drop/second, and keeping the pressure and the temperature until the distillation is finished to obtain the IBOMA with extremely low or even no MEHQ content in the distillation flask. After distillation, removing the heat source, opening the screw clamp of the rubber tube on the capillary, slowly opening the piston on the safety bottle, balancing the internal and external pressure, and finally closing the air pump.
2. The specific operation method of HPMA rectification is as follows: adding HPMA into a double-neck distillation flask until the liquid to be distilled reaches 1/2 of the volume of the flask, closing a piston on a safety bottle, adjusting the pressure in the distillation flask to 93.325pa by using an oil pump, starting heating by using an oil bath after the pressure is stabilized, controlling the temperature of a hot bath at 45 ℃, preferably controlling the distillation speed to be 0.5-1 drop/second, keeping the pressure and the temperature constant until the distillation is finished, and obtaining the HPMA with extremely low or even no MEHQ content in a receiver. After distillation, removing the heat source, opening the screw clamp of the rubber tube on the capillary, slowly opening the piston on the safety bottle, balancing the internal and external pressure, and finally closing the air pump.
2, 6-di-tert-butyl-p-cresol (BHT polymerization inhibitor) which is screened is added before vacuum distillation in order to prevent the product from polymerizing in the rectification process.
Through the reduced pressure distillation mode, monomers such as PEGDA (polyethylene glycol diacrylate), PEGDMA (polyethylene glycol dimethacrylate), PEGD400MA, PEGD400A and the like can be obtained through rectification.
Synthesis of oligomer PUA:
the advantage of the choice of the blocking agent required for the synthesis of oligomeric PUA, of the hydroxyl-functional methacrylate-type reactive monomers (e.g.HPMA, HEMA) over the choice of the hydroxyl-functional acrylate-type monomers (e.g.HPA, HEA), is:
the hydroxyl functional acrylate active monomer containing methyl has the advantages of more stable property than hydroxyl functional acrylate due to the existence of methyl, such as better hydrolysis resistance, better optical stability, more difficult double bond rotation, increased molecular weight, reduced volatilization rate, reduced anaphylaxis, better toughness, better wear resistance and reduced irritation.
Although the HEMA can not be used as a reactive diluent in personal methyl oil gel, the HEMA can be used as an end-capping agent of resin to participate in the synthesis of the resin, and the HEMA content in the system after the reaction is finished is very low or even none.
Thus, oligomer PUA with hydroxyl-functionalized methacrylate-based reactive monomers (HPMA, HEMA, etc.) as blocking agents was chosen.
The polyurethane acrylate consists of dihydric alcohol, isocyanate, a blocking agent, a catalyst and a polymerization inhibitor; wherein:
the isocyanate is one of the following: IPDI CAS No 4098-71-9 Isophorone diisocyanate, H12MDI CAS No5124-30-1 dicyclohexylmethane-4, 4-diisocyanate, HDI CAS No 822-06-0 hexamethylene diisocyanate.
The dihydric alcohol is one of the following: polytetrahydrofuran and copolyether glycols thereof, polytetrahydrofuran glycol (PTMEG) CASNo: 25190-06-01,24979-97-3. Polybutylene adipate diol CAS No25103-87-1, polydiethylene adipate diol CAS No27925-07-1, polyhexamethylene adipate diol CAS No25212-06-0, polyethylenepropylene adipate diol CAS No26523-14-8, polydiethylene adipate diol CAS No25214-18-0, polytetramethylene adipate hexanediol CAS No25214-15-7, polyhexamethylene adipate neopentyl glycol CAS No25214-14-6, polycarbonic acid-1.6-hexanediol CAS No101325-00-2, polycarbonic acid cyclohexane dimethanol-1.6-hexanediol diol CAS No216691-97-3, polycarbonic acid-1.5-pentanediol-1.6-hexanediol CAS No 459-81-5, 1.4-butanediol-1.6-hexanediol polycarbonate CAS No149295-53-4, BDO polycaprolactone diol CAS No331831-53-5, NPG polycaprolactone diol CAS No69089-45-8, HDO polycaprolactone diol CAS No36609-29-7 L205AL.L208AL.L212AL.L220AL.L220PM.230AL.220NPI and other polycaprolactone CAS No86630-69-5, PTXG-1000, PDA-2000, PEDA-2000B and PETA-2000.
The end-capping agent is a methacrylate functionalized by hydroxyl; can be HPMA CAS NO 26099-09-02, HEMA CAS NO 868-77-9.
The catalyst comprises the following components: dibutyltin dilaurate, tetrabutylammonium bromide, triethylamine or triphenylphosphine were used.
The reaction route for synthesizing the polyurethane acrylate (PUA) comprises the following steps: diol is reacted with isocyanate to synthesize NCO-terminated polyurethane prepolymer, which is then reacted with hydroxyl-functionalized methacrylate to introduce methacryloxy. The preparation method comprises the following steps:
(1) firstly, adding dihydric alcohol into a four-neck flask provided with a mechanical stirring device, a thermometer and a vacuum device, and dehydrating for 1h at the temperature of 110 ℃ and the vacuum degree of 0.88 MPa;
(2) reducing the temperature of the dehydrated dihydric alcohol material to 65 ℃, keeping the temperature constant, adding isocyanate (the molar ratio of the glycol to the isocyanate is 1: 1) in a titration mode, and continuing to react for 1.5h after the titration is finished;
(3) reducing the temperature to 60 ℃, then adding a blocking agent, adding 2, 6-di-tert-butyl-p-cresol (BHT polymerization inhibitor) and a catalyst into a four-neck flask, reacting at a constant temperature, and stopping the reaction when the NCO content is reduced to below 0.1%;
(4) finally, the UV-cured resin with low MEHQ content and low skin irritation is prepared.
The UV curable resins synthesized by the present inventors through the above manner have been subjected to related certifications on INCI and CAS No by replacing different types of the above isocyanates, diols, and blocking agents to prepare different functional light curable resins, and specific types are LT2010, LT2012, LT2013, LT2015, LT2016, LT2017, LT2018, LT2019, LT2020, LT2021, LT2022, LT2023, LT2024, LT2025, LT2026, and LT 2027. The method comprises the following specific steps:
trade name | CAS number | Name of Chinese |
LT2010 | 2134562-92-6 | Bis-hydroxyethyl methacrylate (1, 4-butanediol-1, 6-hexanediol polycarbonate) -/isophorone diisocyanate copolymer |
LT2012 | 2123611-93-6 | Bis-hydroxyethyl methacrylate (poly-epsilon-caprolactone-neopentyl glycol ester diol) -/isophorone diisocyanate copolymer |
LT2013 | 2134098-86-3 | Bis-hydroxyethyl methacrylate (polytetrahydrofuran diol) -/isophorone diisocyanate copolymer |
LT2015 | 2134562-93-7 | Bis-hydroxyethyl methacrylate (poly-1, 4-butanediol adipate-diol) -/isophorone diisocyanate copolymer |
LT2016 | 2134562-94-8 | bis-HPMA (Poly (trimethylene adipate) glycol) -/isophorone diisocyanate copolymer |
LT2017 | 2134562-95-9 | Bis-hydroxyethyl methacrylate (poly-3-methyl-1, 5-pentanediol adipate) -/isophorone diisocyanate copolymer |
LT2018 | 2139340-54-6 | Bis-hydroxyethyl methacrylate (poly-epsilon-caprolactone-1, 4-butanediol ester diol) -/isophorone diisocyanate copolymer |
LT2020 | 2139340-35-3 | Bis-hydroxyethyl methacrylate (poly (1, 5-pentanediol-1, 6-hexanediol) diol) -/isophorone diisocyanate copolymer |
LT2021 | 2389147-80-0 | Bis-hydroxyethyl methacrylate (poly neopentyl glycol-tetrahydrofuran ether glycol) -/isophorone diisocyanate copolymer |
LT2022 | 2389147-81-1 | Bis-hydroxyethyl methacrylate (poly (diethylene glycol adipate glycol) -/isophorone diisocyanate copolymer |
LT2023 | 2389129-40-0 | Bis-hydroxyethyl methacrylate (poly (ethylene glycol-diethylene glycol ester diol) -/isophorone diisocyanate copolymer |
LT2024 | 2389147-82-2 | Bis-hydroxyethyl methacrylate (poly (ethylene glycol-trimethylolpropane ester diol))/isophorone diisocyanate copolymer |
LT2025 | 2389147-83-3 | Bis-hydroxyethyl methacrylate (poly-epsilon-caprolactone-1, 6-hexanediol) -/isophorone diisocyanate copolymer |
LT2026 | 2389147-84-4 | Bis-hydroxyethyl methacrylate (poly-epsilon-caprolactone-diglycol ester diol) -/isophorone diisocyanate copolymer |
LT2027 | 2389147-85-5 | Bis-hydroxyethyl methacrylate (poly (1, 4-cyclohexanedimethanol-1, 6-hexanediol) diol)/isophorone diisocyanate copolymer |
The nail polish gel prepared by screening the photoinitiator, distilling the active diluent under reduced pressure and selecting the end-capping agent synthetic resin with low skin irritation through the obtained materials can meet the use requirements of individuals using UV phototherapy nail polish gel and meet the individual use standards of European Union.
Further, the nail polish glue is used for preparing a primer, and the primer comprises the following components in parts by mass:
LT 201035-45 parts
LT 201827-37 parts
25-35 parts of HPMA
1841-4 parts
TPO-L1-4 parts
0.1-0.5 part of BYK-333 leveling agent.
The primer formula takes HPMA as a diluent monomer, and mainly has the effects of reducing curing shrinkage, increasing film-forming property and improving adhesive force by matching with LT2010 and LT2018 oligomers, and finally promoting deep curing and complete surface curing by using a photoinitiator matched with TPO-L and 184.
In the preferred embodiment, the primer comprises the following components in parts by weight:
LT 201040 parts
LT2018 32
30 portions of HPMA
1843.5 parts
TPO-L3 parts
0.3 part of BYK-333 leveling agent.
Further, the nail polish gel is used for preparing a color gel, and the color gel comprises the following components in parts by mass:
LT 202138-48 parts
LT 201313-23 parts
20-30 parts of PEG400DA 20
5-15 parts of HPMA
1841-4 parts
8190.1-3 parts
TPO-L1-4 parts
0.2-0.5 part of BYK-333 leveling agent
0.1 to 2 portions of color paste
0.1-1.6 parts of R974 anti-settling agent.
The color paste uses PEG400DA monomer to increase curing speed, and the crosslinking density is improved while the brittleness after film forming is not too poor, HPMA is helpful to improve the wetting dispersibility of the pigment, high-efficiency photoinitiator 819 and TPO are matched to compete with the pigment to absorb light to promote deep curing to be complete, and finally R974 anti-settling agent is added to ensure that the color paste is dispersed stably and prevent settling.
In the preferred embodiment, the color glue comprises the following components in parts by weight:
LT 202143 parts
LT 201318 parts
PEG400DA 25 part
10 portions of HPMA
1843 parts of
8192 parts
TPO-L3 parts
0.3 part of BYK-333 leveling agent
Color paste 1 part
And 1.2 parts of R974 anti-settling agent.
Further, the nail polish glue is used for preparing a seal layer, and the seal layer comprises the following components in parts by mass:
LT 201037-47 parts
LT 201520-30 parts
13-23 parts of PEGDMA
10-20 parts of HPMA
TPO-L3-5 parts
0.1-0.5 part of BYK-333 leveling agent.
The sealing layer is a scrubbing formula, so that the problem of surface oxygen inhibition can be avoided, a TPO-L initiator is added to promote the bottom layer to be completely cured, the PEGDMA with good glossiness, the LT2010 and the LT2015 are matched, and the formula toughness is improved by the HPMA.
In the preferred embodiment, the seal layer comprises the following components in parts by weight:
LT 201042 parts
LT 201523 part
PEGDMA 18 parts
HPMA 15 parts
TPO-L4 parts
0.3 part of BYK-333 leveling agent.
In conclusion, the nail polish gel meeting the use standard of European Union individuals eliminates TPO and MEHQ which are harmful substances to human bodies, and active diluents with low skin irritation to the human bodies, does not use HEMA which is an active diluent, and selects PUA with low skin irritation, thereby reducing allergic factors to the human bodies and ensuring the use safety of individuals. The nail polish gel has the advantages of easy operation, low irritation, long retention time, wide application range, safety and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. A nail polish gel meeting the use standard of European Union individuals is characterized in that the raw materials of the nail polish gel comprise an oligomer, a photoinitiator and a reactive diluent which is treated by reduced pressure distillation;
the oligomer is urethane acrylate;
the photoinitiator consists of one or more of 184 photoinitiator, 1173 photoinitiator, 819 photoinitiator and TPO-L photoinitiator;
the reactive diluent treated by reduced pressure distillation does not comprise HEMA.
2. A nail polish gel according to the eu personal use standards according to claim 1, wherein: the polyurethane acrylate is composed of dihydric alcohol, isocyanate, a blocking agent, a catalyst and a polymerization inhibitor.
3. A nail polish gel according to the eu personal use standards according to claim 2, wherein: the isocyanate is isophorone diisocyanate, dicyclohexylmethane-4, 4-diisocyanate or hexamethylene diisocyanate.
4. A nail polish gel according to the eu personal use standards according to claim 2, wherein: the catalyst is dibutyltin dilaurate, tetrabutylammonium bromide, triethylamine or triphenylphosphine.
5. A nail polish gel according to the eu personal use standards according to claim 2, wherein: the end-capping agent is a methacrylate functionalized with hydroxyl groups.
6. A nail polish gel according to the eu personal use standards according to claim 2, wherein: the dihydric alcohol is polytetrahydrofuran and copolyether glycol thereof, polytetrahydrofuran diol, polybutylene adipate diol, polyethylene glycol adipate diol, polyhexamethylene glycol adipate diol, polyethylene glycol propylene glycol adipate diol, polyethylene glycol adipate diol, polybutylene glycol adipate diol, polyethylene glycol neopentyl glycol adipate diol, 1.6-hexanediol polycarbonate diol, cyclohexane dimethanol-1.6-hexanediol polycarbonate diol, 1.5-pentanediol-1.6-hexanediol polycarbonate diol, 1.4-butanediol-1.6-hexanediol polycarbonate diol, polycaprolactone diol or polycaprolactone diol.
7. A nail polish gel according to the eu personal use standards according to claim 2, wherein: the polymerization inhibitor is 2, 6-di-tert-butyl-p-cresol.
8. A nail polish gel according to the eu personal use standards according to claim 1, wherein: the nail polish glue is used for preparing a primer, and the primer comprises the following components in parts by mass:
LT 201035-45 parts
LT 201827-37 parts
25-35 parts of HPMA
1-4 parts of 184 photoinitiator
TPO-L photoinitiator 1-4 parts
0.1-0.5 part of BYK-333 leveling agent.
9. A nail polish gel according to the eu personal use standards according to claim 1, wherein: the nail polish gel is used for preparing a color gel, and the color gel comprises the following components in parts by weight:
LT 202138-48 parts
LT 201313-23 parts
20-30 parts of PEG400DA 20
5-15 parts of HPMA
1-4 parts of 184 photoinitiator
819 parts of photoinitiator 0.1-3
TPO-L photoinitiator 1-4 parts
0.2-0.5 part of BYK-333 leveling agent
0.1 to 2 portions of color paste
0.1-1.6 parts of R974 anti-settling agent.
10. A nail polish gel according to the eu personal use standards according to claim 1, wherein: the nail polish glue is used for preparing a sealing layer, and the sealing layer comprises the following components in parts by mass:
LT 201037-47 parts
LT 201520-30 parts
13-23 parts of PEGDMA
10-20 parts of HPMA
3-5 parts of TPO-L photoinitiator
0.1-0.5 part of BYK-333 leveling agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011133930.6A CN112168742A (en) | 2020-10-21 | 2020-10-21 | Nail polish gel meeting European Union personal use standard |
CN2020111339306 | 2020-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113456535A true CN113456535A (en) | 2021-10-01 |
Family
ID=73922494
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011133930.6A Pending CN112168742A (en) | 2020-10-21 | 2020-10-21 | Nail polish gel meeting European Union personal use standard |
CN202110977353.7A Pending CN113456535A (en) | 2020-10-21 | 2021-08-24 | Nail polish gel meeting European Union personal use standard |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011133930.6A Pending CN112168742A (en) | 2020-10-21 | 2020-10-21 | Nail polish gel meeting European Union personal use standard |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN112168742A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114903816A (en) * | 2022-06-06 | 2022-08-16 | 东莞市百拓实业有限公司 | Nail polish gel and preparation method thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112168742A (en) * | 2020-10-21 | 2021-01-05 | 广东蓝天优创美化妆品有限公司 | Nail polish gel meeting European Union personal use standard |
CN113185945A (en) * | 2021-04-28 | 2021-07-30 | 广东蓝天优创美化妆品有限公司 | UV/LED cured transparent extension adhesive with low heat release and rapid curing and preparation method thereof |
CN113244128A (en) * | 2021-05-13 | 2021-08-13 | 广东蓝天优创美化妆品有限公司 | Odor-free and ultralow-VOC-emission nail polish gel and preparation method thereof |
CN114634598B (en) * | 2022-02-17 | 2024-04-26 | 无锡八禾新材料科技有限公司 | Preparation method of acrylic polyurethane for nail polish gel |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040151691A1 (en) * | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
DE102013016013A1 (en) * | 2012-09-27 | 2014-04-17 | Adalbert Schmid | Light-curing nail polish, useful in a light-curing modeling gel for producing an artificial nail, comprises a light-curing urethane methacrylate and a flowing agent |
CN105748317A (en) * | 2016-02-23 | 2016-07-13 | 上海应用技术学院 | Quickly-curing strippable nail polish gel and preparation method thereof |
CN107595669A (en) * | 2017-08-31 | 2018-01-19 | 河源然生新材料有限公司 | A kind of peelable ground beetle factice of environmental protection and preparation method thereof |
CN112168742A (en) * | 2020-10-21 | 2021-01-05 | 广东蓝天优创美化妆品有限公司 | Nail polish gel meeting European Union personal use standard |
-
2020
- 2020-10-21 CN CN202011133930.6A patent/CN112168742A/en active Pending
-
2021
- 2021-08-24 CN CN202110977353.7A patent/CN113456535A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040151691A1 (en) * | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
DE102013016013A1 (en) * | 2012-09-27 | 2014-04-17 | Adalbert Schmid | Light-curing nail polish, useful in a light-curing modeling gel for producing an artificial nail, comprises a light-curing urethane methacrylate and a flowing agent |
CN105748317A (en) * | 2016-02-23 | 2016-07-13 | 上海应用技术学院 | Quickly-curing strippable nail polish gel and preparation method thereof |
CN107595669A (en) * | 2017-08-31 | 2018-01-19 | 河源然生新材料有限公司 | A kind of peelable ground beetle factice of environmental protection and preparation method thereof |
CN112168742A (en) * | 2020-10-21 | 2021-01-05 | 广东蓝天优创美化妆品有限公司 | Nail polish gel meeting European Union personal use standard |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114903816A (en) * | 2022-06-06 | 2022-08-16 | 东莞市百拓实业有限公司 | Nail polish gel and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112168742A (en) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113456535A (en) | Nail polish gel meeting European Union personal use standard | |
CN102924683B (en) | Aqueous polyurethane dispersoid for coating yellowing-resistant leather and preparation method thereof | |
CN107075301B (en) | Removable coating system and method | |
US8846011B2 (en) | Curable resin composition for covering a fingernail or artificial fingernail | |
CN105440260B (en) | UV-cured polyurethane acrylate and preparation method thereof | |
Zareanshahraki et al. | “Green” UV‐LED gel nail polishes from bio‐based materials | |
FR2496113A1 (en) | COATING COMPOSITIONS FOR FLEXIBLE CARRIERS BASED ON POLYESTER RESINS CURABLE BY VAPOR PERMEATION | |
IE83277B1 (en) | UV curable clearcoat compositions and process | |
CN1863745B (en) | Radiation-hardenable coating agent containing aliphatic urethane(meth)acrylate | |
EP0583355A4 (en) | Uv curable blend compositions and processes | |
CN101993531B (en) | Vinyl modified polyester polyatomic alcohol, two-part curable paint composition and condensate | |
CN102782065A (en) | Coating agent composition | |
KR20150011505A (en) | Water-soluble paint composition and method for producing the same | |
CN112080185A (en) | Waterborne polyurethane industrial paint and preparation method thereof | |
WO2004083327A1 (en) | Uv curable paint composition with high operating efficiency | |
EP3572474B1 (en) | Biomaterial-based uv coating composition | |
JP6632870B2 (en) | Soft-feel paint composition for one-time coating | |
CN112592435A (en) | Bio-based aqueous light-cured nail polish and preparation method thereof | |
KR100385910B1 (en) | Photocurable coating composition containing urethane acrylate oligomer | |
KR101098988B1 (en) | Waterborne urethane resin and Waterborne urethane-acylate resin having core ?shell form | |
JP2016141634A (en) | Composition for raw material of artificial nail | |
EP4151120A1 (en) | Nail sticker, and composition for nail sticker and preparation method therefor | |
CN113576144B (en) | Composition for nail sticker and preparation method thereof | |
CA2885809C (en) | Sunlight curable coating compositions | |
US20070137524A1 (en) | Coating composition for soft feel coating on surface or portable terminals and electronic instruments and method for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211001 |